
PRN · 2026-11-17 11:06 UTC
CC Loss Alert: Chemours Investors Sued for Securities Fraud in Connection with 18% Stock Drop and Alleged Misrepresentations about its Opteon Demand
A securities fraud class action was filed against The Chemours Company (NYSE:CC) and certain senior executives, alleging they misrepresented demand strength for Opteon products. The complaint says Chemours guided to 2026 net sales growth of 3% to 5% and adjusted EBITDA of $800M–$900M, citing higher Opteon demand, while allegedly failing to disclose an oversupplied channel. After Q2 2026 results on August 4, 2026 showed about 1% lower net sales and cut EBITDA guidance to $775M–$825M, the stock fell 18.63%, from $17.93 to $14.59 per share. The lead plaintiff deadline is December 7, 2026.
Loading the story on Tree News…